z-logo
open-access-imgOpen Access
Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion
Author(s) -
Domenico G. Della Rocca,
Rodney Horton,
Nicola Tarantino,
Christoffel Johannes Van Niekerk,
Chintan Trivedi,
Qiong Chen,
Sanghamitra Mohanty,
Alisara Anannab,
Ghulam Murtaza,
Krishna Akella,
Carola Gianni,
Mohamed Bassiouny,
Ashkan Ahmadian-Tehrani,
Amin AlAhmad,
J. David Burkhardt,
Veronica Natale,
Matthew J. Price,
G. Joseph Gallinghouse,
Douglas Gibson,
Dhanunjaya Lakkireddy,
Luigi Di Biase,
Andrea Natale
Publication year - 2020
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.120.009227
Subject(s) - medicine , percutaneous , occlusion , fluoroscopy , surgery , atrial appendage , ligation , stroke (engine) , atrial fibrillation , appendage , thromboembolic stroke , cardiology , anatomy , mechanical engineering , sinus rhythm , engineering
Background: Interventional therapies aiming at excluding the left atrial appendage (LAA) from systemic circulation have been established as a valid alternative to oral anticoagulation in patients at high thromboembolic risk. However, their efficacy on stroke prophylaxis may be compromised owing to incomplete LAA closure. Additionally, the need for an alternative thromboembolic prevention may remain unmet in patients with contraindications to oral anticoagulation whose appendage anatomy is unsuitable for some conventional devices commercially available. We aimed at evaluating the feasibility of LAA closure with the novel Gore Cardioform Septal Occluder in patients with incomplete appendage ligation or anatomic features which do not meet the manufacturer’s requirements for Watchman deployment. Methods: Twenty-one consecutive patients (mean age: 72±6 years; 85.7% males; CHA2 DS2 -VASc: 4.5±1.4; HAS-BLED: 3.6±1.0) were included. Transesophageal echocardiography was performed within 2 months to assess for residual LAA patency.Results: Fourteen patients had incomplete LAA closure following surgical (n=6) or Lariat ligation (n=8). In 7 patients with an appendage anatomy unsuitable for Watchman deployment, the mean maximal landing zone size and LAA depth were 14.4±1.3 and 18.6±2.8 mm. Successful Cardioform Septal Occluder deployment was achieved in all patients. No peri-procedural complications were documented. Procedure and fluoroscopy times were 46±13 and 14±5 minutes. Follow-up transesophageal echocardiography after 58±9 days revealed complete LAA closure in all patients. Conclusions: Transcatheter LAA closure via a Cardioform Septal Occluder device might be a valid alternative in patients with residual leaks following failed appendage ligation or whose LAA anatomy does not meet the minimal anatomic criteria to accommodate a Watchman device. Graphic Abstract: Agraphic abstract is available for this article.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom